Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$233.66M
Total Bought:
$31.55M
Total Sold:
$21.63M
Net Transaction:
+$9.92M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and CompanyCOM(LLY)34,60238,721+4,119$28.58M$30.18M12.92%+$1.61M
AbbVie Inc.COM(ABBV)89,22786,933-2,294$18.69M$16.14M6.91%-$2.56M
Boston Scientific CorporationCOM(BSX)132,273126,185-6,088$13.34M$13.55M5.80%+$209.8K
Neurocrine Biosciences, Inc.COM(NBIX)75,88188,392+12,511$8.39M$11.11M4.75%+$2.72M
Merck & Co., Inc.COM(MRK)127,679139,172+11,493$11.46M$11.02M4.71%-$443.6K
Stryker CorporationCOM(SYK)22,99827,466+4,468$8.56M$10.87M4.65%+$2.31M
Vertex Pharmaceuticals IncorporatedCOM(VRTX)22,80824,328+1,520$11.06M$10.83M4.64%-$226.9K
Intuitive Surgical, Inc.COM NEW(ISRG)15,34518,559+3,214$7.60M$10.09M4.32%+$2.49M
Thermo Fisher Scientific Inc.COM(TMO)22,85724,266+1,409$11.37M$9.84M4.21%-$1.53M
Cencora IncCOM31,55331,466-87$8.77M$9.44M4.04%+$660.5K
Gilead Sciences, Inc.COM(GILD)76,99873,165-3,833$8.63M$8.11M3.47%-$515.8K
BridgeBio Pharma, Inc.COM(BBIO)151,348165,480+14,132$5.23M$7.15M3.06%+$1.91M
Amgen Inc.COM(AMGN)26,57723,894-2,683$8.28M$6.67M2.86%-$1.61M
Alkermes plcSHS(ALKS)214,778227,224+12,446$7.09M$6.50M2.78%-$591.1K
BeOne Medicines AGSPONSORED ADS(ONC)25,14124,386-755$6.84M$5.90M2.53%-$939.5K
Mirum Pharmaceuticals, Inc.COM(MIRM)77,263106,912+29,649$3.48M$5.44M2.33%+$1.96M
UFP Technologies, Inc.COM(UFPT)21,25921,886+627$4.29M$5.34M2.29%+$1.06M
Cardinal Health, Inc.COM(CAH)27,68826,797-891$3.81M$4.50M1.93%+$687.3K
Edwards Lifesciences CorpCOM59,69657,360-2,336$4.33M$4.49M1.92%+$159.4K
VERONA PHARMA PLC - ADRSPONSORED ADS34,69047,100+12,410$2.20M$4.45M1.91%+$2.25M
DexCom, Inc.COM NEW(DXCM)45,84150,872+5,031$3.13M$4.44M1.90%+$1.31M
iRhythm Holdings, Inc.COM(IRTC)20,54725,302+4,755$2.15M$3.90M1.67%+$1.74M
Soleno Therapeutics IncCOM37,09840,532+3,434$2.65M$3.40M1.45%+$745.1K
Merus N.V.COM35,29259,889+24,597$1.49M$3.15M1.35%+$1.66M
Revolution Medicines, Inc.COM(RVMD)54,96182,275+27,314$1.94M$3.03M1.30%+$1.08M
NewAmsterdam Pharma Co NVORDINARY SHARES
ORDINARY SHARES
107,783157,223+49,440$2.21M$2.85M1.22%+$641.0K
Krystal Biotech, Inc.COM(KRYS)23,49120,158-3,333$4.24M$2.77M1.19%-$1.46M
Harmony Biosciences Holdings, Inc.COM(HRMY)91,30186,274-5,027$3.03M$2.73M1.17%-$304.0K
Autolus Therapeutics plcSPON ADS(AUTL)479,6441,105,461+625,817$743.4K$2.52M1.08%+$1.78M
UnitedHealth Group IncorporatedCOM(UNH)25,78213,727-12,055$13.50M$2.49M1.06%-$11.02M
Mereo BioPharma Group plcSPON ADS(MREO)390,000764,901+374,901$877.5K$2.07M0.89%+$1.20M
Summit Therapeutics Inc.COM(SMMT)105,07792,737-12,340$2.03M$1.97M0.84%-$53.5K
Arcellx IncCOMMON STOCK
COMMON STOCK
44,17125,732-18,439$2.90M$1.69M0.73%-$1.20M
BICARA THERAPEUTICS INCCOM119,833147,380+27,547$1.56M$1.37M0.59%-$192.3K
Disc Medicine, Inc.COM(IRON)024,652+24,652$0$1.31M0.56%+$1.31M
Corbus Pharmaceuticals Holdings, Inc.COM(CRBP)98,304175,582+77,278$522.0K$1.21M0.52%+$689.5K
Janux Therapeutics, Inc.COM(JANX)46,80849,820+3,012$1.26M$1.15M0.49%-$113.0K
Cabaletta Bio, Inc.(CABA)182,3540-182,354$252.6K$0—-$252.6K
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q2 2025 | TickerTrail